Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis.

October 11, 2019

Paradoxical psoriasis or psoriasiform lesion is an adverse effect, represented by the occurrence of a psoriasiform lesion or exacerbation of psoriasis caused by the drugs normally used for the management of psoriasis. In this article, we present the first case of a 45-year-old male patient with rheumatoid arthritis who developed psoriasiform lesions following treatment with tofacitinib, and highlight the possible pathogenetic mechanisms involved in such an occurrence.

as reported in: Erol K, Ertaş R. Arch Rheumatol. 2020 Sep:35(3):440-442. doi: 10.46497/ArchRheumatol.2020.7541.